Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Okopien, B; Hyper, M; Kowalski, J; Belowski, D; Madej, A; Zielinski, M; Tokarz, D; Kalina, Z; Herman, ZS
   A new immunological marker of atherosclerotic injury of arterial wall
   RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY
   
   B. Okopien et al., "A new immunological marker of atherosclerotic injury of arterial wall", RES COM M P, 109(3-4), 2001, pp. 241-248
2. Kowalski, J; Okopien, B; Madej, A; Makowiecka, K; Zielinski, M; Kalina, Z; Herman, ZS
   Levels of sICAM-1 sVCAM-1 and MCP-1 in patients with hyperlipoproteinemia IIa and -IIb
   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
   
   J. Kowalski et al., "Levels of sICAM-1 sVCAM-1 and MCP-1 in patients with hyperlipoproteinemia IIa and -IIb", INT J CL PH, 39(2), 2001, pp. 48-52
3. Okopien, B; Cwalina, L; Lebek, M; Kowalski, J; Zielinski, M; Wisniewska-Wanat, M; Kalina, Z; Herman, ZS
   Effects of fibrates on plasma prothrombotic activity in patients with TypeIIb dyslipidemia
   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
   
   B. Okopien et al., "Effects of fibrates on plasma prothrombotic activity in patients with TypeIIb dyslipidemia", INT J CL PH, 39(12), 2001, pp. 551-557
4. MADEJ A; OKOPIEN B; KOWALSKI J; ZIELINSKI M; WYSOCKI J; SZYGULA B; KALINA Z; HERMAN ZS
   EFFECTS OF FENOFIBRATE ON PLASMA CYTOKINE CONCENTRATIONS IN PATIENTS WITH ATHEROSCLEROSIS AND HYPERLIPOPROTEINEMIA IIB
   International journal of clinical pharmacology and therapeutics
   
   A. Madej et al., "EFFECTS OF FENOFIBRATE ON PLASMA CYTOKINE CONCENTRATIONS IN PATIENTS WITH ATHEROSCLEROSIS AND HYPERLIPOPROTEINEMIA IIB", International journal of clinical pharmacology and therapeutics, 36(6), 1998, pp. 345-349
5. KOWALSKI J; OKOPIEN B; MADEJ A; ZIELINSKI M; KALINA Z; HERMAN ZS
   THE ACTIVITY OF LYMPHOCYTES ISOLATED FROM HYPERLIPIDEMIC PATIENTS TREATED WITH FENOFIBRATE
   Naunyn-Schmiedeberg's archives of pharmacology
   
   J. Kowalski et al., "THE ACTIVITY OF LYMPHOCYTES ISOLATED FROM HYPERLIPIDEMIC PATIENTS TREATED WITH FENOFIBRATE", Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 2027-2027
6. OKOPIEN B; KALINA Z; MADEJ A; KOWALSKI J; SZYGULA B; ZIELINSKI M; HERMAN ZS
   THE RELEASE OF CYTOKINES BY CULTURED MACROPHAGES FROM HYPERLIPIDEMIC PATIENTS TREATED WITH MICRONIZED FENOFIBRATE
   Atherosclerosis
   
   B. Okopien et al., "THE RELEASE OF CYTOKINES BY CULTURED MACROPHAGES FROM HYPERLIPIDEMIC PATIENTS TREATED WITH MICRONIZED FENOFIBRATE", Atherosclerosis, 134(1-2), 1997, pp. 281-282
7. OKOPIEN B; TRZCIAK HI
   MODIFICATION OF ADRENERGIC REACTIVITY IN RAT TAIL ARTERY BY DIETARY LIPIDS AND CALCIUM-CHANNEL ANTAGONISTS
   General pharmacology
   
   B. Okopien e H.I. Trzciak, "MODIFICATION OF ADRENERGIC REACTIVITY IN RAT TAIL ARTERY BY DIETARY LIPIDS AND CALCIUM-CHANNEL ANTAGONISTS", General pharmacology, 27(5), 1996, pp. 895-900
8. TRZECIAK HI; OKOPIEN B; KOZLOWSKI A; CHOCILOWSKA D; BARA A
   CONTRACTILITY OF THE TAIL ARTERY IN RATS TREATED WITH BEZAFIBRATE ANDFED ATHEROGENIC DIET
   Journal of cardiovascular pharmacology
   
   H.I. Trzeciak et al., "CONTRACTILITY OF THE TAIL ARTERY IN RATS TREATED WITH BEZAFIBRATE ANDFED ATHEROGENIC DIET", Journal of cardiovascular pharmacology, 22(5), 1993, pp. 761-767